Financials in USD. Standardized financial statements.
A compact view of how Alimera Sciences, Inc. turns revenue into operating income and net income.
| Metric | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue? | $80.75M | $54.13M | $59.03M | $50.82M | $53.94M | $46.97M | $35.91M | $34.33M | $22.44M | $8.42M |
| Revenue Growth? | +49.2% | -8.3% | +16.2% | -5.8% | +14.8% | +30.8% | +4.6% | +53.0% | +166.4% | 0.0% |
| Cost of Revenue? | $19.58M | $7.98M | $7.03M | $6.94M | $6.63M | $4.31M | $3.44M | $2.34M | $1.76M | $1.44M |
| Gross Profit? | $61.17M | $46.15M | $52.00M | $43.88M | $47.32M | $42.29M | $32.47M | $31.99M | $20.68M | $6.98M |
| Gross Margin? | +75.7% | +85.3% | +88.1% | +86.3% | +87.7% | +90.0% | +90.4% | +93.2% | +92.1% | +82.9% |
| Operating Expenses? | $62.64M | $57.79M | $52.20M | $44.38M | $52.59M | $49.32M | $51.78M | $59.84M | $59.67M | $39.93M |
| Operating Income? | -$1.93M | -$11.64M | -$201,000 | -$501,000 | -$5.27M | -$9.67M | -$16.45M | -$27.85M | -$39.00M | -$32.95M |
| EBITDA? | -$1.11M | -$9.49M | $4.06M | $2.65M | -$2.72M | -$8.86M | -$13.57M | -$25.06M | -$23.27M | -$32.99M |
| Income Before Tax | -$20.05M | -$18.08M | -$3.93M | -$5.41M | -$10.23M | -$16.28M | -$21.84M | -$33.00M | -$30.52M | -$35.74M |
| Income Tax Expense | $85,000 | $28,000 | $438,000 | -$68,000 | $216,000 | $106,000 | $163,000 | $172,000 | $130,000 | $174,000 |
| Net Income? | -$20.13M | -$18.11M | -$4.37M | -$5.34M | -$10.44M | -$16.38M | -$22.00M | -$33.17M | -$30.64M | -$35.91M |
| EPS? | $-0.79 | $-2.59 | $-0.66 | $-1.04 | $-2.19 | $3.75 | $-4.93 | $-9.42 | $-10.34 | $-13.33 |
| Diluted EPS? | $-0.79 | $-2.59 | $-0.66 | $-1.04 | $-2.19 | $3.75 | $-4.93 | $-9.42 | $-10.34 | $-13.33 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality